Parkinsonism
Conditions
Keywords
Parkinson's disease, gait
Brief summary
The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who are able to provide informed consent will participate in the assessments. Outcome variables include selected gait and balance parameters such as cadence, gait-cycle, stride-length, stride-velocity, turning duration, turning steps, postural sway and anticipatory postural control. These parameters will be measured by the portable inertial sensors developed by APDM® and the Zeno/GaitRite.
Detailed description
Testing Participants after screening and consenting will: 1. Have their height measured and fit with the APDM Opals (each device is a two inch square attached by velcro), one device is attached to each leg, each arm, and the trunk and chest and receive an introduction to walking on the gait mat. 2. Participants are then asked to walk at a self selected walking speed down the gait mat. The participants will complete multiple passes (8-10 passes, total 75-100 feet) across the gait mat while wearing the APDM units to concurrently collect all temporal and spatial data needed to answer the research question. The Zeno mat is the intended primary gait mat for this study. The GaitRite will only be utilized in the case of a technical issue with the Zeno in order to insure completion of the data collection.
Interventions
OTHERGAITRite
mobility test assessing gait parameters
OTHERADPM
mobility test assessing gait parameters
Sponsors
University of Texas Southwestern Medical Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Adults between the ages of 18 and 80 years of age with a primary diagnosis of PD and similar parkinsonian syndromes 2. Individuals able to walk 100 feet independently, with or without the use of an assistive device (walker, cane) and follow simple instructions. 3. Individuals with sufficient physiological systemic support to participate in the study protocol
Exclusion criteria
1. Inability to speak English secondary to the need to understand and follow multistep directions 2. A secondary diagnosis (musculoskeletal, cardiopulmonary, neurological) that excludes participation in the study 3. Inability to ambulate 100 feet independently with or without an assistive device. 4. Inability to follow simple instructions necessary for completion of the testing tasks.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| gait parameters | one year | Outcome variables include selected gait and balance such as cadence |
Countries
United States
Outcome results
None listed